Note: Ingredients listed on restricted chemical lists
EC/CAS
9002-93-1
Name of the chemical
Octylphenolethoxylates (OPEO)
Concentration
=0,25-<1,0
EC/CAS
21416-85-3
Name of the chemical
potassium dimethylarsinate
Concentration
=2,5-<10,0
EC/CAS
231-589-4/7791-13-1
Name of the chemical
Cobalt (II) chloride, hexahydrate
Concentration
>=0,01-< >=0,01%
General Information
Revision date
2021-08-16
Product name
In Situ Cell Death TMR
1.2.1 Relevant identified uses
For use in research only on use
Emergency telephone
In case of emergencies
Icons in SDS
Company Information
company name
Roche Diagnostics Deutschland GmbH
e-mail address of the competent person responsible for the Safety Data Sheet
info.dia-sds@roche.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H350i, H411
Hazard statements
Code
Statements
H350i
May cause cancer by inhalation
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
The product is a kit consisting of individual ingredients. The classification of the ingredients can be obtained from section 3. Section Label elements contains the resulting labelling for the kit.
Signal word
Danger
Hazard statements
H350i May cause cancer by inhalation. H411 Toxic to aquatic life with long lasting effects.
Prevention
P201 Obtain special instructions before use. P273 Avoid release to the environment. P280 Wear protective gloves/ protective clothing/ eye protec- tion/ face protection/ hearing protection.
Response
P308 + P313 IF exposed or concerned: Get medical advice/ attention. P391 Collect spillage.
Disposal
P501 Dispose of contents/ container to an approved waste disposal plant.
Additional information
Restricted to professional users.
ECOLOGICAL INFORMATION
This substance/mixture contains components considered to have endo- crine disrupting properties for environment , according to REACH Article 57(f), Commission Regulation (EU) 2018/605 or Commission Delegated Regulation (EU) 2017/2100.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
